Print copies of the Educational Book and Annual Meeting Proceedings may be purchased through theASCO Bookstoreto be picked up onsite or shipped to your home or office (shipping charges apply). Please note books will mail in mid-May and receipt before Annual Meeting cannot be guarenteed. REGIST...
As reported in the Journal of Clinical Oncology by Alexander Drilon, MD, of Memorial Sloan Kettering Cancer Center and Weill Cornell Medical Center, New York, and colleagues, final results of the registrational phase I/II LIBRETTO-001 trial showed continued benefit of the RET receptor tyrosine....
Namodenoson has received significant acknowledgment in the scientific and medical communities, as evidenced by the numerous peer-reviewed publications and conferences, in which it has been published and presented. “Our Phase 3 registrational trial is designed to treat patients who have ...
Currently being evaluated in a pivotal Phase 3 multinational registration trial for the treatment of HCC and underlying Child Pugh B7, Namodenoson has also completely cleared cancer in an HCC patient who was enrolled in Can-Fite’s Phase ...